Click for best price
Chronic Intestinal Inflammation Treatment Drug Market Size, Share 2024
The global Chronic Intestinal Inflammation Treatment Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Amino-salicylates Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Chronic Intestinal Inflammation Treatment Drug include Abbott Laboratories, Biocon Ltd, Roche, Johnson and Johnson, Mylan Pharmaceuticals, Novartis AG, Pfizer, Quest Medical and Sanofi, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Intestinal Inflammation Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Intestinal Inflammation Treatment Drug. This report contains market size and forecasts of Chronic Intestinal Inflammation Treatment Drug in global, including the following market information:
Global Chronic Intestinal Inflammation Treatment Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Chronic Intestinal Inflammation Treatment Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chronic Intestinal Inflammation Treatment Drug Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Chronic Intestinal Inflammation Treatment Drug Market Segment Percentages, by Type, 2023 (%)
Amino-salicylates
Antibiotics
Corticosteroids
Immunomodulators
Biologics
Others
Global Chronic Intestinal Inflammation Treatment Drug Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Chronic Intestinal Inflammation Treatment Drug Market Segment Percentages, by Application, 2023 (%)
Ulcerative Colitis
Crohns Disease
Others
Global Chronic Intestinal Inflammation Treatment Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Chronic Intestinal Inflammation Treatment Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chronic Intestinal Inflammation Treatment Drug revenues in global market, 2019-2024 (estimated), ($ millions)
Key companies Chronic Intestinal Inflammation Treatment Drug revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Biocon Ltd
Roche
Johnson and Johnson
Mylan Pharmaceuticals
Novartis AG
Pfizer
Quest Medical
Sanofi
Takeda Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Chronic Intestinal Inflammation Treatment Drug, market overview.
Chapter 2: Global Chronic Intestinal Inflammation Treatment Drug market size in revenue.
Chapter 3: Detailed analysis of Chronic Intestinal Inflammation Treatment Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Chronic Intestinal Inflammation Treatment Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Chronic Intestinal Inflammation Treatment Drug Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Chronic Intestinal Inflammation Treatment Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Chronic Intestinal Inflammation Treatment Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Chronic Intestinal Inflammation Treatment Drug Overall Market Size
2.1 Global Chronic Intestinal Inflammation Treatment Drug Market Size: 2023 VS 2030
2.2 Global Chronic Intestinal Inflammation Treatment Drug Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Chronic Intestinal Inflammation Treatment Drug Players in Global Market
3.2 Top Global Chronic Intestinal Inflammation Treatment Drug Companies Ranked by Revenue
3.3 Global Chronic Intestinal Inflammation Treatment Drug Revenue by Companies
3.4 Top 3 and Top 5 Chronic Intestinal Inflammation Treatment Drug Companies in Global Market, by Revenue in 2023
3.5 Global Companies Chronic Intestinal Inflammation Treatment Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Chronic Intestinal Inflammation Treatment Drug Players in Global Market
3.6.1 List of Global Tier 1 Chronic Intestinal Inflammation Treatment Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Chronic Intestinal Inflammation Treatment Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Chronic Intestinal Inflammation Treatment Drug Market Size Markets, 2023 & 2030
4.1.2 Amino-salicylates
4.1.3 Antibiotics
4.1.4 Corticosteroids
4.1.5 Immunomodulators
4.1.6 Biologics
4.1.7 Others
4.2 By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue & Forecasts
4.2.1 By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2024
4.2.2 By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2025-2030
4.2.3 By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Chronic Intestinal Inflammation Treatment Drug Market Size, 2023 & 2030
5.1.2 Ulcerative Colitis
5.1.3 Crohns Disease
5.1.4 Others
5.2 By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue & Forecasts
5.2.1 By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2024
5.2.2 By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2025-2030
5.2.3 By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Chronic Intestinal Inflammation Treatment Drug Market Size, 2023 & 2030
6.2 By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue & Forecasts
6.2.1 By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2024
6.2.2 By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2025-2030
6.2.3 By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030
6.3.2 US Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.3.3 Canada Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.3.4 Mexico Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030
6.4.2 Germany Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.3 France Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.4 U.K. Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.5 Italy Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.6 Russia Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.7 Nordic Countries Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.4.8 Benelux Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030
6.5.2 China Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.5.3 Japan Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.5.4 South Korea Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.5.5 Southeast Asia Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.5.6 India Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030
6.6.2 Brazil Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.6.3 Argentina Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030
6.7.2 Turkey Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.7.3 Israel Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.7.4 Saudi Arabia Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
6.7.5 UAE Chronic Intestinal Inflammation Treatment Drug Market Size, 2019-2030
7 Chronic Intestinal Inflammation Treatment Drug Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.1.4 Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Biocon Ltd
7.2.1 Biocon Ltd Company Summary
7.2.2 Biocon Ltd Business Overview
7.2.3 Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.2.4 Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.2.5 Biocon Ltd Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.3.4 Roche Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.3.5 Roche Key News & Latest Developments
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Company Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.4.4 Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.4.5 Johnson and Johnson Key News & Latest Developments
7.5 Mylan Pharmaceuticals
7.5.1 Mylan Pharmaceuticals Company Summary
7.5.2 Mylan Pharmaceuticals Business Overview
7.5.3 Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.5.4 Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.5.5 Mylan Pharmaceuticals Key News & Latest Developments
7.6 Novartis AG
7.6.1 Novartis AG Company Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.6.4 Novartis AG Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.6.5 Novartis AG Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.7.4 Pfizer Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Quest Medical
7.8.1 Quest Medical Company Summary
7.8.2 Quest Medical Business Overview
7.8.3 Quest Medical Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.8.4 Quest Medical Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.8.5 Quest Medical Key News & Latest Developments
7.9 Sanofi
7.9.1 Sanofi Company Summary
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.9.4 Sanofi Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.9.5 Sanofi Key News & Latest Developments
7.10 Takeda Pharmaceutical
7.10.1 Takeda Pharmaceutical Company Summary
7.10.2 Takeda Pharmaceutical Business Overview
7.10.3 Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Major Product Offerings
7.10.4 Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Revenue in Global Market (2019-2024)
7.10.5 Takeda Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Chronic Intestinal Inflammation Treatment Drug Market Opportunities & Trends in Global Market
Table 2. Chronic Intestinal Inflammation Treatment Drug Market Drivers in Global Market
Table 3. Chronic Intestinal Inflammation Treatment Drug Market Restraints in Global Market
Table 4. Key Players of Chronic Intestinal Inflammation Treatment Drug in Global Market
Table 5. Top Chronic Intestinal Inflammation Treatment Drug Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Chronic Intestinal Inflammation Treatment Drug Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Chronic Intestinal Inflammation Treatment Drug Revenue Share by Companies, 2019-2024
Table 8. Global Companies Chronic Intestinal Inflammation Treatment Drug Product Type
Table 9. List of Global Tier 1 Chronic Intestinal Inflammation Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Chronic Intestinal Inflammation Treatment Drug Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Chronic Intestinal Inflammation Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Chronic Intestinal Inflammation Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Chronic Intestinal Inflammation Treatment Drug Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Chronic Intestinal Inflammation Treatment Drug Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2025-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 32. Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Biocon Ltd Company Summary
Table 35. Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 36. Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 37. Biocon Ltd Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 40. Roche Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 41. Roche Key News & Latest Developments
Table 42. Johnson and Johnson Company Summary
Table 43. Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 44. Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 45. Johnson and Johnson Key News & Latest Developments
Table 46. Mylan Pharmaceuticals Company Summary
Table 47. Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 48. Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 49. Mylan Pharmaceuticals Key News & Latest Developments
Table 50. Novartis AG Company Summary
Table 51. Novartis AG Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 52. Novartis AG Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 53. Novartis AG Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 56. Pfizer Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Quest Medical Company Summary
Table 59. Quest Medical Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 60. Quest Medical Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 61. Quest Medical Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 64. Sanofi Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 65. Sanofi Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Summary
Table 67. Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Product Offerings
Table 68. Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Revenue (US$, Mn) & (2019-2024)
Table 69. Takeda Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Chronic Intestinal Inflammation Treatment Drug Segment by Type in 2023
Figure 2. Chronic Intestinal Inflammation Treatment Drug Segment by Application in 2023
Figure 3. Global Chronic Intestinal Inflammation Treatment Drug Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Chronic Intestinal Inflammation Treatment Drug Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Chronic Intestinal Inflammation Treatment Drug Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Chronic Intestinal Inflammation Treatment Drug Revenue in 2023
Figure 8. By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 9. By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 10. By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 12. By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 14. By Region - Global Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 15. By Country - North America Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 16. US Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 20. Germany Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 21. France Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 28. China Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 32. India Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 34. Brazil Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Chronic Intestinal Inflammation Treatment Drug Revenue Market Share, 2019-2030
Figure 37. Turkey Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Chronic Intestinal Inflammation Treatment Drug Revenue, (US$, Mn), 2019-2030
Figure 41. Abbott Laboratories Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Biocon Ltd Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Roche Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Johnson and Johnson Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Mylan Pharmaceuticals Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Novartis AG Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Quest Medical Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Sanofi Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Takeda Pharmaceutical Chronic Intestinal Inflammation Treatment Drug Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
